Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Penumbra (NYSE: PEN) announced its management team will present at the 44th Annual J.P.
Rhea-AI Summary
Penumbra (NYSE: PEN) announced its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 6:45pm ET / 3:45pm PT.
A live webcast will be available on the company website under Investors > Events and Presentations and will remain accessible for at least two weeks after the event.
Details
News Market Reaction – PEN
On Dec 30, the first trading day after this news, PEN closed 0.20% below the previous close.
Data tracked by StockTitan Argus for the Dec 30 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- J.P. Morgan Healthcare Conference
- Presentation time ET
- 6:45 PM ET
- Conference presentation slot
- Presentation time PT
- 3:45 PM PT
- Conference presentation slot
- Webcast availability
- At least two weeks
- Replay on company investor website
Historical Context
-
Piper Sandler healthcare conference presentation with webcast for investors.
-
Q3 2025 revenue growth, strong margins, and raised full-year guidance.
-
STORM-PE trial showed improved outcomes for pulmonary embolism patients.
-
STORM-PE RCT showed CAVT plus anticoagulation superior to anticoagulation alone.
-
Scheduled TCT investor event and timing of Q3 2025 earnings release.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: | 44th Annual J.P. Morgan Healthcare Conference |
Date: | Monday, January 12, 2026 |
Time: | 6:45pm ET/3:45pm PT |
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302640354.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.